Nouveauté

ESCAPE Study: Cannabidiol use in patients treated for substance use disorders, prevalence of use, and characteristics of users

M. DUVAL ; M. ISTVAN ; M. ROUSSELET ; E. J. LAFORGUE ; M. GRALL-BRONNEC ; C. MAURIAT ; C. VICTORRI-VIGNEAU | 2025
Dans European Addiction Research (Vol.31, n°1, April 2025) Article : Périodique

INTRODUCTION: Cannabidiol (CBD) is one of the two primary phytocannabinoids found in cannabis. Its diverse pharmacological properties suggest potential benefits for a wide range of medical conditions. The primary objective of this study was to e[...]

Plus d'info

Ajouter à la sélection

Lien externe

"Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose

A. AQUIZERATE ; M. ROUSSELET ; A. COCHARD ; M. GUERLAIS ; M. GÉRARDIN ; E. LEFEBVRE ; M. DUVAL ; E. J. LAFORGUE ; C. VICTORRI-VIGNEAU | 2024
Dans Harm Reduction Journal (Vol.21, 2024) Article : Périodique

BACKGROUND: Opioid-related mortality is a rising public health concern in France, where opioids were in 2021 implicated in 75% of overdose deaths. Opioid substitution treatment (OST) was implicated in almost half of deaths related to substance a[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nitrous oxide: a unique official French addictovigilance national survey

M. GUERLAIS ; A. AQUIZERATE ; A. LIONNET ; A. DAVELUY ; M. DUVAL ; M. GÉRARDIN ; M. ISTVAN ; E. J. LAFORGUE ; C. VICTORRI-VIGNEAU | 2023
Dans Frontiers in Public Health (Vol.11, 2023) Article : Périodique

INTRODUCTION: Nitrous oxide has become over the last few years a public health problem in many countries. France has a dedicated health monitoring system dedicated to the surveillance of the abuse, dependence and consequences associated with the[...]

Plus d'info

Ajouter à la sélection

Lien externe

Physicians, pharmacists and take-home naloxone: What practices? The SINFONI study

M. DUVAL ; A. AQUIZERATE ; E. JAULIN ; M. ROUSSELET ; E. KUHN ; A. GUILLEMINOT ; I. NICOLLEAU ; S. PELE ; T. HERAULT ; P. ARTARIT ; E. SOULIDOU-JACQUES ; E. J. LAFORGUE ; C. VICTORRI-VIGNEAU | 2024
Dans Therapies (Vol.79, n°6, Novembre-Décembre 2024) Article : Périodique

Objective: For several years, both the French Addictovigilance Network and French health authorities have consistently emphasized the need to provide opioid users with take-home naloxone (THN), the specific antidote for opioid overdoses. In Marc[...]

Plus d'info

Ajouter à la sélection

Lien externe